SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0000935836-19-000129
Filing Date
2019-02-14
Accepted
2019-02-14 14:37:02
Documents
1

Document Format Files

Seq Description Document Type Size
1 onconova13ga1.htm SC 13G/A 45316
  Complete submission text file 0000935836-19-000129.txt   46949
Mailing Address 375 PHEASANT RUN NEWTOWN PA 18940
Business Address 375 PHEASANT RUN NEWTOWN PA 18940 267-759-3681
Onconova Therapeutics, Inc. (Subject) CIK: 0001130598 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87566 | Film No.: 19604760
SIC: 2834 Pharmaceutical Preparations

Mailing Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158
Business Address 409 ILLINOIS STREET SAN FRANCISCO CA 94158 415-448-6534
EcoR1 Capital, LLC (Filed by) CIK: 0001587114 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A